Skip to main content
Log in

Myocardial revascularization in patients with end-stage renal disease: Comparison of percutaneous transluminal coronary angioplasty and coronary artery bypass grafting

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Background: Ischemic heart disease is the major cause of death inpatients with end-stage renal disease. The high prevalence of coronary artery disease results in a rising number of dialysis patients requiring myocardial revascularisation. Objective: The objective of this study was to compare the outcomes of recurrent angina, myocardial infarction, rate of reinterventions and cardiovascular death following percutaneous coronary angioplasty (PTCA) or coronary artery bypass grafting (CABG) inpatients with end-stage renal disease. Patients and methods: In a retrospective investigation 40 patients with chronic renal failure undergoing primarily PTCA and 65 patients undergoing CABG were included. Both groups were comparable for gender, duration on dialysis and the number of cardiovascular risk factors per patient. Patients undergoing PTCA were younger (53 ± 12 years vs. 57 ± 8 years; p < 0.05) and more often diabetics (30% vs. 14%; p < 0.05). Results: Most patients in both groups had a multi-vessel disease (95% in the CABG group vs. 74% in the PTCA group), in the CABG group there were significantly more patients with a triple-vessel disease (62% with vs. 40%in the PTCA group; p < 0.01), PTCA was primarily successful in 95% of the patients while complete revascularization was achieved in 88% of patients undergoing CABG. The perioperative mortality after CABG was 4.8% as compared to none after interventional revascularisation. The cumulative freedom of angina after 6, 12 and 24 months after intervention was significantly lower after PTCA (54%, 40%, 29%) than after bypass grafting (97%, 94%, 90%, p < 0.001). The frequency of reinterventions following PTCA was significantly higher compared to patients following CABG (p < 0.001). After PTCA 15 patients needed further revascularisations, 8 of them underwent CABG, whereas after CABG only two patients required additional myocardial revascularisation. There was no significant difference in the overall mortality between both groups; the survival rate after 12 and 24 months was 95% and 82% after PTCA and 93% and 86% after CABG, respectively. Condition: Although patients receiving CABG had a more severe coronary artery disease the overall mortality was comparable and clinical and functional outcome was improved compared to patients after coronary angioplasty.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ahmed WH, Shubrooks SJ, Gibson MC, Baim DS, Bittle JA. Complications and long-term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients. Am Heart J 1994; 126: 252.

    Article  Google Scholar 

  2. Apple G. Lipid abnormalities in renal disease. Kidney Int 1991; 39: 169.

    Google Scholar 

  3. BARI Investigators: Comparison of coronary artery bypass surgery with angioplasty in patients with multlivessel disease. N Engl J Med 1994; 335: 217.

    Google Scholar 

  4. Batiuk TD, Kurtz SB, Oh JK, Orszulak TA. Coronary artery bypass operation in dialysis patients. Mayo Clin Proc 1991; 66: 45.

    PubMed  CAS  Google Scholar 

  5. Elezi E, Kastrati A, Pache J. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol 1998; 32: 1866.

    Article  PubMed  CAS  Google Scholar 

  6. Gradaus F, Schoebel FC, Ivens K, Peters A, Heering P, Leschke M, Grabensee B, Strauer BE. Progression of coronary artery disease in patients with chronic renal failure. J Am Coll Cardiol 1999; (Suppl. 1): 340 A.

    Google Scholar 

  7. Gris JC, Branger B, Vecina F, Al Sabadani BA, Fourcade J, Schved JF. Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients. Kidney Int 1994; 46: 807.

    PubMed  CAS  Google Scholar 

  8. Gum PA, O'Keefe JH, Borkon AM. Bypass surgery versus coronary angioplasty for revascularization of treated diabetic patients. Circulation 1997; 96(Suppl. II): 7.

    Google Scholar 

  9. Hässler R, Höfling B, Castro L. Koronare Herzkrankheit und Herzklappen-erkrankungen bei Patienten mit terminaler Niereninusffizienz. Dtsch Med Wschrft 1987; 112: 714.

    Google Scholar 

  10. Hamm CW, Reimers J, Ischinger T. A randomized study in coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. N Engl J Med 1994; 331: 1037.

    Article  PubMed  CAS  Google Scholar 

  11. Herzog CA, Ma JZ, Cllins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998; 339: 799.

    Article  PubMed  CAS  Google Scholar 

  12. Ilson BE, Bland PS, Jorkasky DK. Intraoperative versus routine hemodialysis in end-stage renal disease patients undergoing open-heart surgery. Nephron 1992; 61: 170.

    Article  PubMed  CAS  Google Scholar 

  13. Ivens K, Keering P, Leschke M. Kardiochirurgische Therapie der koronaren Herzkrankheit bei Patienten mit terminaler Niereninusffizienz. Dtsch Med Wschr 1996; 121: 788.

    PubMed  CAS  Google Scholar 

  14. Kahn JK, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Hartlzer GO. Short-and long term outcome of percutaneous transluminal angioplasty in chronic dialysis patients. Am Heart J 1990; 119: 484.

    PubMed  CAS  Google Scholar 

  15. King SB, Lembo NJ, Weintraub WS. A randomised trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med 1994; 331: 1044.

    Article  PubMed  Google Scholar 

  16. Koch M, Gradaus F, Schoebel FC, Leschke M, Grabensee B. Relevance of conventional cardiovascular risk factors for the prediction of coronary artery disease in diabetic patients with renal replacement therapy. Nephrol Dial Transplant 1997; 12: 1187.

    Article  PubMed  CAS  Google Scholar 

  17. Kornowski R, Mintz GS, Kent KM. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperlasia. A serial ultrasound study. Circulation 1997; 95: 1366.

    PubMed  CAS  Google Scholar 

  18. Koyanagi T, Nishida H, Kitamaru M. Comparison of clinical outcomes of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in renal dialysis patients. Ann Thorac Surg 1996; 61: 1793.

    Article  PubMed  CAS  Google Scholar 

  19. Manske CL, Wilson RA, Wang Y, Thomas W. Athrosclerotic vascular complications in diabetic transplantations candidates. Am J Kidney Dis 1997; 29: 601.

    PubMed  CAS  Google Scholar 

  20. Mezzano D, Tagle R, Panes O. Hemostatic disorder of uremia. The platelet defect, main determinant of the prolonged bleeding time, is correlated with indeces of activation od coagulation and fibrinolysis. Thromb Haemost 1996; 76(3): 312.

    PubMed  CAS  Google Scholar 

  21. Opsahl JA, Husebye DG, Helesth HK, Collins AJ. Coronary artery bypass surgery in patients on maintenance dialysis: Longterm survival. Am J Kidney Dis 1998; 12: 271.

    Google Scholar 

  22. Raine AEG, Margreiter R, Brunner FP. Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant 1992; 7(Suppl 2): 7.

    PubMed  Google Scholar 

  23. Reusser LM, Osborn LA, White HJ, Sexson R, Crawford MH. Increased morbidity after coronary angioplasty in patients on chronic Hemodialysis. Am J Cardiol 1994; 73: 965.

    Article  PubMed  CAS  Google Scholar 

  24. Rinehart A, Herzog CA, Collins AJ, Flack JM, Ma JZ, Opsahl JA. A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis 1995; 25: 281.

    PubMed  CAS  Google Scholar 

  25. RITA Trial participants: Coronary angioplasty versus coronary artery bypass surgery: The Randomised Intervention Treatment of Angina (RITA) trial. Lancet 1995; 343: 573.

    Google Scholar 

  26. Rostand SG, Kirk KA, Rutsky EA, Pacifico AD. Results of coronary artery bypass grafting in end-stage renal disease. Am J Kidney Dis 1988; 12: 266.

    PubMed  CAS  Google Scholar 

  27. Schoebel FC, Gradaus F, Ivens K, Restenosis after elective coronary balloon angioplasty in patients with end-stage renal disease: a case control study using quantitative coronary angiography. Heart, 1997; 78: 337.

    PubMed  CAS  Google Scholar 

  28. United States Renal Data System. (USRD): Annual report Bethesda Maryland, USA. National Institute of Diabetes and Digestive and Kidney disease: Am J Kidney Dis 1996; 26: 17.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ivens, K., Gradaus, F., Heering, P. et al. Myocardial revascularization in patients with end-stage renal disease: Comparison of percutaneous transluminal coronary angioplasty and coronary artery bypass grafting. Int Urol Nephrol 32, 717–723 (2001). https://doi.org/10.1023/A:1015067611958

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015067611958

Navigation